ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxxiii.xmlNCCN News2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxxiii.pdf2026-04-18NCCN Newshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxlviii.xmlOncology Research Program2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxlviii.pdf2026-04-18Oncology Research Programhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxlix.xml JNCCN CE Offerings2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-pxlix.pdf2026-04-18 JNCCN CE Offeringshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1199.xmlOvarian Cancer, Version 2.20132026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1199.pdf2026-04-18Ovarian Cancer, Version 2.2013https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1193.xmlBarriers to Treatment in Patients With Locally Advanced Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1193.pdf2026-04-18Barriers to Treatment in Patients With Locally Advanced Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1187.xmlImatinib-Induced Bone Edema: Case Report and Review of Literature2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1187.pdf2026-04-18Imatinib-Induced Bone Edema: Case Report and Review of Literaturehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1181.xmlMoving Forward With Myeloid Growth Factors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1181.pdf2026-04-18Moving Forward With Myeloid Growth Factorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1227.xmlHematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromes2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1227.pdf2026-04-18Hematopoietic Stem Cell Transplantation for Older Patients With Myelodysplastic Syndromeshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1211.xmlComputer/Online-Mediated Social Support for Cancer-Related Fatigue2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1211.pdf2026-04-18Computer/Online-Mediated Social Support for Cancer-Related Fatiguehttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1219.xmlAdolescent and Young Adult Colorectal Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1219.pdf2026-04-18Adolescent and Young Adult Colorectal Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1235.xmlTargeting Angiogenesis in Advanced Non-Small Cell Lung Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1235.pdf2026-04-18Targeting Angiogenesis in Advanced Non-Small Cell Lung Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1249.xmlImplementing Routine Screening for Distress, the Sixth Vital Sign, for Patients With Head and Neck and Neurologic Cancers2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1249.pdf2026-04-18Implementing Routine Screening for Distress, the Sixth Vital Sign, for Patients With Head and Neck and Neurologic Cancershttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1291.xmlWill Biosimilars Gain Momentum?2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1291.pdf2026-04-18Will Biosimilars Gain Momentum?https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1266.xmlMyeloid Growth Factors2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1266.pdf2026-04-18Myeloid Growth Factorshttps://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1298.xmlPerspectives on Surveillance and Survivorship: When to Make the Transition2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/11/10/article-p1298.pdf2026-04-18Perspectives on Surveillance and Survivorship: When to Make the Transition